Mizuho Securities USA LLC Buys 84,897 Shares of Humana Inc. (NYSE:HUM)

Mizuho Securities USA LLC raised its stake in shares of Humana Inc. (NYSE:HUM) by 914.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 94,183 shares of the insurance provider’s stock after acquiring an additional 84,897 shares during the quarter. Mizuho Securities USA LLC owned approximately 0.08% of Humana worth $29,832,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Creative Financial Designs Inc. ADV lifted its holdings in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. increased its holdings in shares of Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares in the last quarter. Atwood & Palmer Inc. bought a new position in shares of Humana in the third quarter valued at approximately $29,000. Ashton Thomas Securities LLC acquired a new position in shares of Humana in the 3rd quarter worth approximately $31,000. Finally, Your Advocates Ltd. LLP grew its position in Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after acquiring an additional 45 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

HUM has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft decreased their target price on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a report on Thursday, October 3rd. Truist Financial decreased their price objective on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a report on Friday, October 11th. Oppenheimer reduced their target price on shares of Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. JPMorgan Chase & Co. increased their price target on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Finally, KeyCorp initiated coverage on shares of Humana in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $315.86.

Humana Stock Performance

Shares of HUM opened at $275.67 on Friday. The firm has a market cap of $33.19 billion, a P/E ratio of 24.42, a PEG ratio of 2.29 and a beta of 0.52. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $527.18. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The firm’s 50 day moving average price is $281.36 and its two-hundred day moving average price is $331.61.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, analysts forecast that Humana Inc. will post 15.83 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.28%. Humana’s dividend payout ratio is currently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.